These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15980334)

  • 1. Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.
    Pini A; Giuliani A; Falciani C; Runci Y; Ricci C; Lelli B; Malossi M; Neri P; Rossolini GM; Bracci L
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2665-72. PubMed ID: 15980334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity.
    Pini A; Giuliani A; Falciani C; Fabbrini M; Pileri S; Lelli B; Bracci L
    J Pept Sci; 2007 Jun; 13(6):393-9. PubMed ID: 17486663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide derived from phage display library exhibits antibacterial activity against E. coli and Pseudomonas aeruginosa.
    Sainath Rao S; Mohan KV; Atreya CD
    PLoS One; 2013; 8(2):e56081. PubMed ID: 23409125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homo and Hetero-Branched Lipopeptide Dendrimers: Synthesis and Antimicrobial Activity.
    Lamba S; Heruka De Zoysa G; Wang K; Lu J; Swift S; Sarojni V
    Bioorg Chem; 2024 Sep; 150():107567. PubMed ID: 38936047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, antimicrobial activity and LPS-interaction properties of SB041, a novel dendrimeric peptide with antimicrobial properties.
    Bruschi M; Pirri G; Giuliani A; Nicoletto SF; Baster I; Scorciapino MA; Casu M; Rinaldi AC
    Peptides; 2010 Aug; 31(8):1459-67. PubMed ID: 20438783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo design of potent antimicrobial peptides.
    Frecer V; Ho B; Ding JL
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3349-57. PubMed ID: 15328096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship study using peptide arrays to optimize Api137 for an increased antimicrobial activity against Pseudomonas aeruginosa.
    Bluhm ME; Knappe D; Hoffmann R
    Eur J Med Chem; 2015 Oct; 103():574-82. PubMed ID: 26408816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and mechanisms of the secondary structure on the antimicrobial activity and specificity of antimicrobial peptides.
    Mai XT; Huang J; Tan J; Huang Y; Chen Y
    J Pept Sci; 2015 Jul; 21(7):561-8. PubMed ID: 25826179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent antimicrobial peptide analogs of Ixosin-B.
    Lung FD; Wang KS; Liao ZJ; Hsu SK; Song FY; Liou CC; Wu YS
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4185-8. PubMed ID: 22578463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphiphilic cationic β(3R3)-peptides: membrane active peptidomimetics and their potential as antimicrobial agents.
    Mosca S; Keller J; Azzouz N; Wagner S; Titz A; Seeberger PH; Brezesinski G; Hartmann L
    Biomacromolecules; 2014 May; 15(5):1687-95. PubMed ID: 24694059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.
    Cerovský V; Slaninová J; Fucík V; Hulacová H; Borovicková L; Jezek R; Bednárová L
    Peptides; 2008 Jun; 29(6):992-1003. PubMed ID: 18375018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.
    Wu YS; Liao ZJ; Wang KS; Lung FD
    Bioorg Med Chem Lett; 2013 May; 23(10):2929-32. PubMed ID: 23570790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational modification of a dendrimeric peptide with antimicrobial activity: consequences on membrane-binding and biological properties.
    Batoni G; Casu M; Giuliani A; Luca V; Maisetta G; Mangoni ML; Manzo G; Pintus M; Pirri G; Rinaldi AC; Scorciapino MA; Serra I; Ulrich AS; Wadhwani P
    Amino Acids; 2016 Mar; 48(3):887-900. PubMed ID: 26614437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving short antimicrobial peptides despite elusive rules for activity.
    Mikut R; Ruden S; Reischl M; Breitling F; Volkmer R; Hilpert K
    Biochim Biophys Acta; 2016 May; 1858(5):1024-33. PubMed ID: 26687790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.
    Knappe D; Ruden S; Langanke S; Tikkoo T; Ritzer J; Mikut R; Martin LL; Hoffmann R; Hilpert K
    Amino Acids; 2016 Jan; 48(1):269-80. PubMed ID: 26334348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic dendrimeric peptide active against biofilm and persister cells of Pseudomonas aeruginosa.
    Bahar AA; Liu Z; Totsingan F; Buitrago C; Kallenbach N; Ren D
    Appl Microbiol Biotechnol; 2015 Oct; 99(19):8125-35. PubMed ID: 26012420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo antimicrobial peptides with low mammalian cell toxicity.
    Javadpour MM; Juban MM; Lo WC; Bishop SM; Alberty JB; Cowell SM; Becker CL; McLaughlin ML
    J Med Chem; 1996 Aug; 39(16):3107-13. PubMed ID: 8759631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of multidrug resistant Listeria monocytogenes by peptides isolated from combinatorial phage display libraries.
    Flachbartova Z; Pulzova L; Bencurova E; Potocnakova L; Comor L; Bednarikova Z; Bhide M
    Microbiol Res; 2016; 188-189():34-41. PubMed ID: 27296960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activities and action mechanism studies of transportan 10 and its analogues against multidrug-resistant bacteria.
    Xie J; Gou Y; Zhao Q; Li S; Zhang W; Song J; Mou L; Li J; Wang K; Zhang B; Yang W; Wang R
    J Pept Sci; 2015 Jul; 21(7):599-607. PubMed ID: 25891396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
    Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
    J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.